Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2027-2031

Market Size (2025)

USD 2.31 Billion

CAGR (2026-2031)

29.17%

Fastest Growing Segment

Mental Health & Behavioral Monitoring

Largest Market

North America

Market Size (2031)

USD 10.73 Billion

Market Overview

The Global Artificial Intelligence in Remote Patient Monitoring Market is projected to grow from USD 2.31 Billion in 2025 to USD 10.73 Billion by 2031 at a 29.17% CAGR. Artificial Intelligence in Remote Patient Monitoring (AI in RPM) involves the application of artificial intelligence algorithms to process and analyze health data collected from patients outside traditional clinical settings, enabling continuous oversight, early identification of health deviations, and personalized intervention strategies. This market's growth is primarily driven by the increasing global prevalence of chronic diseases, the growing elderly population necessitating ongoing care, and the imperative for healthcare systems to adopt more cost-efficient and accessible service delivery models. Technological advancements in AI and sensor technologies, improving data accuracy and processing capabilities, further support this expansion.

According to the American Telemedicine Association (ATA), in a November 2025 analysis of virtual care across major U.S. health systems, one participating system documented 42,000 nursing hours saved through virtual monitoring, underscoring the efficiency gains enabled by such solutions. Despite these benefits, a significant challenge impeding market expansion is the persistent concern surrounding data privacy and security, as sensitive patient information is collected, transmitted, and stored across various digital platforms.

Key Market Drivers

Rising Chronic Disease Burden
The rising prevalence of chronic diseases stands as a primary catalyst for the Global Artificial Intelligence in Remote Patient Monitoring Market, necessitating continuous and proactive healthcare management beyond traditional clinical settings. Conditions such as cardiovascular diseases, diabetes, and chronic respiratory illnesses require ongoing oversight to prevent complications and reduce hospital readmissions. This growing burden highlights the critical need for solutions that can remotely track patient health, identify early warning signs, and facilitate timely interventions. According to the World Health Organization, in May 2025, nearly three-quarters of the world's population was projected to live with at least one chronic illness, underscoring the vast and expanding patient base that could benefit from AI-powered remote monitoring.

Telehealth Adoption and Digital Health Readiness
Another significant driver is the growing adoption of telehealth and digital health solutions, which provides the technological infrastructure and patient acceptance necessary for AI in RPM to flourish. The integration of virtual care platforms has enabled healthcare providers to extend their reach and offer convenient, accessible services, making remote monitoring a more viable and scalable option. According to the American Telemedicine Association, in May 2026, approximately 80% of hospitals in the U.S. now offer some form of telehealth service, demonstrating widespread institutional acceptance of virtual care. This embrace of digital health facilitates the deployment of AI algorithms to process and analyze the increasing volume of patient data, with Rock Health reporting in January 2026 that AI-enabled digital health companies captured 54% of total funding in 2025, indicating strong investor confidence in these advanced technological applications.

Download Free Sample Report

Key Market Challenges

The persistent concern surrounding data privacy and security presents a significant challenging factor within the global Artificial Intelligence in Remote Patient Monitoring market. This issue directly impedes market expansion by fostering apprehension among both patients and healthcare providers regarding the collection, transmission, and storage of highly sensitive personal health information across digital platforms. Patient reluctance to embrace these technologies stems from fears of unauthorized access, misuse, or breaches of their medical data, which can undermine trust in AI-driven RPM solutions.

Providers, in turn, face stringent regulatory requirements and the potential for substantial legal liabilities and reputational damage in the event of a data compromise. According to the American Medical Association, in March 2026, 86% of physicians emphasized the importance of data privacy as critical for broader AI adoption. This underscores how a pervasive need for robust data protection measures and clear, consistent security protocols slows investment and implementation of AI in RPM, directly hindering the market's overall growth potential and uptake of these innovative care models.

Key Market Trends

The Global Artificial Intelligence in Remote Patient Monitoring Market is significantly shaped by ongoing advancements in predictive analytics and AI algorithms for early intervention. These sophisticated algorithms analyze vast streams of patient data from remote devices, identifying subtle patterns and potential health deteriorations before symptoms become severe. This proactive capability allows healthcare providers to intervene promptly, leading to improved patient outcomes and reduced healthcare burdens. For instance, according to Omdena, in May 2025, in "Predictive Healthcare 2026: Transforming Patient Outcomes", predictive analytics in primary care settings have demonstrated up to a 48% improvement in early disease identification rates for conditions such as diabetes and cardiovascular disease. This trend underscores a pivotal shift from reactive treatment to preventative, data-driven care models, enhancing the value proposition of AI in RPM solutions.

Another critical trend influencing the market is the expansion of Remote Therapeutic Monitoring (RTM) and its supporting reimbursement policies. RTM specifically focuses on the monitoring of non-physiological data, such as therapy adherence and response, broadening the scope of conditions that can be managed remotely with AI assistance. Favorable adjustments in reimbursement frameworks, particularly from regulatory bodies, are incentivizing healthcare providers to adopt and integrate these services more widely. For example, according to "Remote Therapeutic Monitoring 2026: Key Updates in the CMS Proposed Rule", in April 2026, the proposed 2026 qualifying Alternative Payment Model (APM) conversion factor for RTM is $33.59, marking a 3.83% increase from 2025. This growth in reimbursement and coverage makes AI-enabled RTM an increasingly viable and attractive option for extending care outside traditional clinical environments, thereby accelerating market penetration and innovation.

Segmental Insights

The Mental Health & Behavioral Monitoring segment stands out as the fastest-growing application within the Global Artificial Intelligence in Remote Patient Monitoring Market. This rapid expansion is driven by increasing global awareness of mental health challenges and a rising demand for continuous, accessible, and stigma-free support. AI algorithms enable sophisticated analysis of data from wearables and patient reports, detecting subtle shifts in mood, stress, and early indicators of conditions like anxiety or depression. This capability facilitates timely intervention and the development of personalized care plans, enhancing patient safety and supporting clinicians in delivering proactive, data-driven mental healthcare solutions.

Regional Insights

North America consistently leads the Global Artificial Intelligence in Remote Patient Monitoring Market, primarily due to its advanced digital health infrastructure and robust healthcare systems. The region benefits from strong reimbursement frameworks and widespread adoption of telemedicine, which encourage the integration of AI-enabled RPM solutions. Significant investments in digital health initiatives, coupled with supportive government policies and the presence of numerous AI and MedTech businesses, further solidify North America's dominance. Additionally, a high prevalence of chronic diseases and an aging population contribute to the sustained demand for advanced monitoring technologies across the region.

Recent Developments

  • In May 2026, Vivo Care, a technology-enabled provider of Remote Patient Monitoring (RPM), Chronic Care Management (CCM), and Advanced Primary Care Management (APCM) services, announced a new strategic commercial partnership with Onpoint Healthcare Partners. This collaboration aims to integrate Vivo Care’s monitoring capabilities with Onpoint’s AI-enabled panel management solutions. The initiative seeks to lessen clinical and administrative burdens for healthcare providers while delivering consistent, high-quality attention to patients managing chronic conditions. This partnership directly supports the expansion of AI within the global remote patient monitoring market by fostering continuous, patient-centered care models.
  • In April 2026, Memorial Hermann Health System, a large non-profit health system in Texas, partnered with Cadence to implement proactive, AI-enabled remote care for patients with chronic diseases across the Greater Houston area. This collaboration involved introducing both Remote Patient Monitoring (RPM) and Advanced Primary Care Management (APCM) services. The program delivers 24/7 support and real-time vital sign monitoring for conditions such as hypertension and congestive heart failure, equipping clinicians with technology for early interventions and continuous care.
  • In January 2025, PanopticAI achieved FDA clearance for its innovative "Vital Signs" app, marking a significant advancement in AI-powered remote patient monitoring. The application functions as a Software as a Medical Device (SaMD) and utilizes the integrated camera of iPhones and iPads to perform contactless pulse rate measurements through remote photoplethysmography (rPPG) technology. This development offers a non-invasive method for continuous physiological monitoring, enhancing the accessibility and convenience of remote patient care. Such technological breakthroughs contribute to the evolution of the global artificial intelligence in remote patient monitoring market.
  • In 2025, Emory University Hospital Midtown in Atlanta initiated a virtual nursing program, integrating AI-powered technology and telehealth solutions to enhance remote patient care and fall prevention. This innovative deployment included Light Detection and Ranging (LIDAR) technology, designed to continuously monitor patients within their hospital rooms. This strategic move by Emory University Hospital Midtown demonstrates a proactive adoption of artificial intelligence within the remote patient monitoring sector, aiming to improve patient safety and optimize care delivery through advanced digital tools.

Key Market Players

  • Koninklijke Philips N.V.
  • GE HealthCare Technologies Inc.
  • Medtronic plc
  • Siemens Healthineers AG
  • Honeywell International Inc.
  • ResMed Inc.
  • BioTelemetry, Inc.
  • iRhythm Technologies, Inc.
  • Masimo Corporation
  • Abbott Laboratories

By Component

By Clinical Application

By End User

By Region

  • AI-enabled Devices
  • Software & Platform
  • Services
  • Cardiovascular Monitoring
  • Diabetes Management
  • Respiratory Monitoring
  • Oncology Remote Monitoring
  • Mental Health & Behavioral Monitoring
  • Post-operative & Home Recovery
  • Elderly/Frail Patient Monitoring
  • Sleep Disorders & Neurological Monitoring
  • Others
  • Hospitals & Health Systems
  • Home Healthcare Providers
  • Primary Care/Outpatient Clinics
  • Payers & Health Insurers
  • Healthcare Companies
  • Others
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Artificial Intelligence in Remote Patient Monitoring Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Artificial Intelligence in Remote Patient Monitoring Market, By Component:
  • AI-enabled Devices
  • Software & Platform
  • Services
  • Artificial Intelligence in Remote Patient Monitoring Market, By Clinical Application:
  • Cardiovascular Monitoring
  • Diabetes Management
  • Respiratory Monitoring
  • Oncology Remote Monitoring
  • Mental Health & Behavioral Monitoring
  • Post-operative & Home Recovery
  • Elderly/Frail Patient Monitoring
  • Sleep Disorders & Neurological Monitoring
  • Others
  • Artificial Intelligence in Remote Patient Monitoring Market, By End User:
  • Hospitals & Health Systems
  • Home Healthcare Providers
  • Primary Care/Outpatient Clinics
  • Payers & Health Insurers
  • Healthcare Companies
  • Others
  • Artificial Intelligence in Remote Patient Monitoring Market, By Region:
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Artificial Intelligence in Remote Patient Monitoring Market.

Available Customizations:

Global Artificial Intelligence in Remote Patient Monitoring Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Artificial Intelligence in Remote Patient Monitoring Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Artificial Intelligence in Remote Patient Monitoring Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Component (AI-enabled Devices, Software & Platform, Services)

5.2.2.  By Clinical Application (Cardiovascular Monitoring, Diabetes Management, Respiratory Monitoring, Oncology Remote Monitoring, Mental Health & Behavioral Monitoring, Post-operative & Home Recovery, Elderly/Frail Patient Monitoring, Sleep Disorders & Neurological Monitoring, Others)

5.2.3.  By End User (Hospitals & Health Systems, Home Healthcare Providers, Primary Care/Outpatient Clinics, Payers & Health Insurers, Healthcare Companies, Others)

5.2.4.  By Region

5.2.5.  By Company (2025)

5.3.  Market Map

6.    North America Artificial Intelligence in Remote Patient Monitoring Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Component

6.2.2.  By Clinical Application

6.2.3.  By End User

6.2.4.  By Country

6.3.    North America: Country Analysis

6.3.1.    United States Artificial Intelligence in Remote Patient Monitoring Market Outlook

6.3.1.1.  Market Size & Forecast

6.3.1.1.1.  By Value

6.3.1.2.  Market Share & Forecast

6.3.1.2.1.  By Component

6.3.1.2.2.  By Clinical Application

6.3.1.2.3.  By End User

6.3.2.    Canada Artificial Intelligence in Remote Patient Monitoring Market Outlook

6.3.2.1.  Market Size & Forecast

6.3.2.1.1.  By Value

6.3.2.2.  Market Share & Forecast

6.3.2.2.1.  By Component

6.3.2.2.2.  By Clinical Application

6.3.2.2.3.  By End User

6.3.3.    Mexico Artificial Intelligence in Remote Patient Monitoring Market Outlook

6.3.3.1.  Market Size & Forecast

6.3.3.1.1.  By Value

6.3.3.2.  Market Share & Forecast

6.3.3.2.1.  By Component

6.3.3.2.2.  By Clinical Application

6.3.3.2.3.  By End User

7.    Europe Artificial Intelligence in Remote Patient Monitoring Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Component

7.2.2.  By Clinical Application

7.2.3.  By End User

7.2.4.  By Country

7.3.    Europe: Country Analysis

7.3.1.    Germany Artificial Intelligence in Remote Patient Monitoring Market Outlook

7.3.1.1.  Market Size & Forecast

7.3.1.1.1.  By Value

7.3.1.2.  Market Share & Forecast

7.3.1.2.1.  By Component

7.3.1.2.2.  By Clinical Application

7.3.1.2.3.  By End User

7.3.2.    France Artificial Intelligence in Remote Patient Monitoring Market Outlook

7.3.2.1.  Market Size & Forecast

7.3.2.1.1.  By Value

7.3.2.2.  Market Share & Forecast

7.3.2.2.1.  By Component

7.3.2.2.2.  By Clinical Application

7.3.2.2.3.  By End User

7.3.3.    United Kingdom Artificial Intelligence in Remote Patient Monitoring Market Outlook

7.3.3.1.  Market Size & Forecast

7.3.3.1.1.  By Value

7.3.3.2.  Market Share & Forecast

7.3.3.2.1.  By Component

7.3.3.2.2.  By Clinical Application

7.3.3.2.3.  By End User

7.3.4.    Italy Artificial Intelligence in Remote Patient Monitoring Market Outlook

7.3.4.1.  Market Size & Forecast

7.3.4.1.1.  By Value

7.3.4.2.  Market Share & Forecast

7.3.4.2.1.  By Component

7.3.4.2.2.  By Clinical Application

7.3.4.2.3.  By End User

7.3.5.    Spain Artificial Intelligence in Remote Patient Monitoring Market Outlook

7.3.5.1.  Market Size & Forecast

7.3.5.1.1.  By Value

7.3.5.2.  Market Share & Forecast

7.3.5.2.1.  By Component

7.3.5.2.2.  By Clinical Application

7.3.5.2.3.  By End User

8.    Asia Pacific Artificial Intelligence in Remote Patient Monitoring Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Component

8.2.2.  By Clinical Application

8.2.3.  By End User

8.2.4.  By Country

8.3.    Asia Pacific: Country Analysis

8.3.1.    China Artificial Intelligence in Remote Patient Monitoring Market Outlook

8.3.1.1.  Market Size & Forecast

8.3.1.1.1.  By Value

8.3.1.2.  Market Share & Forecast

8.3.1.2.1.  By Component

8.3.1.2.2.  By Clinical Application

8.3.1.2.3.  By End User

8.3.2.    India Artificial Intelligence in Remote Patient Monitoring Market Outlook

8.3.2.1.  Market Size & Forecast

8.3.2.1.1.  By Value

8.3.2.2.  Market Share & Forecast

8.3.2.2.1.  By Component

8.3.2.2.2.  By Clinical Application

8.3.2.2.3.  By End User

8.3.3.    Japan Artificial Intelligence in Remote Patient Monitoring Market Outlook

8.3.3.1.  Market Size & Forecast

8.3.3.1.1.  By Value

8.3.3.2.  Market Share & Forecast

8.3.3.2.1.  By Component

8.3.3.2.2.  By Clinical Application

8.3.3.2.3.  By End User

8.3.4.    South Korea Artificial Intelligence in Remote Patient Monitoring Market Outlook

8.3.4.1.  Market Size & Forecast

8.3.4.1.1.  By Value

8.3.4.2.  Market Share & Forecast

8.3.4.2.1.  By Component

8.3.4.2.2.  By Clinical Application

8.3.4.2.3.  By End User

8.3.5.    Australia Artificial Intelligence in Remote Patient Monitoring Market Outlook

8.3.5.1.  Market Size & Forecast

8.3.5.1.1.  By Value

8.3.5.2.  Market Share & Forecast

8.3.5.2.1.  By Component

8.3.5.2.2.  By Clinical Application

8.3.5.2.3.  By End User

9.    Middle East & Africa Artificial Intelligence in Remote Patient Monitoring Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Component

9.2.2.  By Clinical Application

9.2.3.  By End User

9.2.4.  By Country

9.3.    Middle East & Africa: Country Analysis

9.3.1.    Saudi Arabia Artificial Intelligence in Remote Patient Monitoring Market Outlook

9.3.1.1.  Market Size & Forecast

9.3.1.1.1.  By Value

9.3.1.2.  Market Share & Forecast

9.3.1.2.1.  By Component

9.3.1.2.2.  By Clinical Application

9.3.1.2.3.  By End User

9.3.2.    UAE Artificial Intelligence in Remote Patient Monitoring Market Outlook

9.3.2.1.  Market Size & Forecast

9.3.2.1.1.  By Value

9.3.2.2.  Market Share & Forecast

9.3.2.2.1.  By Component

9.3.2.2.2.  By Clinical Application

9.3.2.2.3.  By End User

9.3.3.    South Africa Artificial Intelligence in Remote Patient Monitoring Market Outlook

9.3.3.1.  Market Size & Forecast

9.3.3.1.1.  By Value

9.3.3.2.  Market Share & Forecast

9.3.3.2.1.  By Component

9.3.3.2.2.  By Clinical Application

9.3.3.2.3.  By End User

10.    South America Artificial Intelligence in Remote Patient Monitoring Market Outlook

10.1.  Market Size & Forecast

10.1.1.  By Value

10.2.  Market Share & Forecast

10.2.1.  By Component

10.2.2.  By Clinical Application

10.2.3.  By End User

10.2.4.  By Country

10.3.    South America: Country Analysis

10.3.1.    Brazil Artificial Intelligence in Remote Patient Monitoring Market Outlook

10.3.1.1.  Market Size & Forecast

10.3.1.1.1.  By Value

10.3.1.2.  Market Share & Forecast

10.3.1.2.1.  By Component

10.3.1.2.2.  By Clinical Application

10.3.1.2.3.  By End User

10.3.2.    Colombia Artificial Intelligence in Remote Patient Monitoring Market Outlook

10.3.2.1.  Market Size & Forecast

10.3.2.1.1.  By Value

10.3.2.2.  Market Share & Forecast

10.3.2.2.1.  By Component

10.3.2.2.2.  By Clinical Application

10.3.2.2.3.  By End User

10.3.3.    Argentina Artificial Intelligence in Remote Patient Monitoring Market Outlook

10.3.3.1.  Market Size & Forecast

10.3.3.1.1.  By Value

10.3.3.2.  Market Share & Forecast

10.3.3.2.1.  By Component

10.3.3.2.2.  By Clinical Application

10.3.3.2.3.  By End User

11.    Market Dynamics

11.1.  Drivers

11.2.  Challenges

12.    Market Trends & Developments

12.1.  Merger & Acquisition (If Any)

12.2.  Product Launches (If Any)

12.3.  Recent Developments

13.    Global Artificial Intelligence in Remote Patient Monitoring Market: SWOT Analysis

14.    Porter's Five Forces Analysis

14.1.  Competition in the Industry

14.2.  Potential of New Entrants

14.3.  Power of Suppliers

14.4.  Power of Customers

14.5.  Threat of Substitute Products

15.    Competitive Landscape

15.1.  Koninklijke Philips N.V.

15.1.1.  Business Overview

15.1.2.  Products & Services

15.1.3.  Recent Developments

15.1.4.  Key Personnel

15.1.5.  SWOT Analysis

15.2.  GE HealthCare Technologies Inc.

15.3.  Medtronic plc

15.4.  Siemens Healthineers AG

15.5.  Honeywell International Inc.

15.6.  ResMed Inc.

15.7.  BioTelemetry, Inc.

15.8.  iRhythm Technologies, Inc.

15.9.  Masimo Corporation

15.10.  Abbott Laboratories

16.    Strategic Recommendations

17.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Artificial Intelligence in Remote Patient Monitoring Market was estimated to be USD 2.31 Billion in 2025.

North America is the dominating region in the Global Artificial Intelligence in Remote Patient Monitoring Market.

Mental Health & Behavioral Monitoring segment is the fastest growing segment in the Global Artificial Intelligence in Remote Patient Monitoring Market.

The Global Artificial Intelligence in Remote Patient Monitoring Market is expected to grow at 29.17% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.